Quick Answer
BioCardia, Inc. reported Stockholders Equity of $895.0 thousand for the year ending 2025.
- BioCardia, Inc. showed an increase of +6.9% in Stockholders Equity from 2024 to 2025.
- This data is from BioCardia, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $13.44 million | Q3 2014: $13.48 million | Q1 2015: $13.62 million | Q2 2015: $13.69 million | Q3 2015: $13.78 million | Q1 2016: $13.95 million | Q2 2016: $14.02 million | Q3 2016: $19.15 million | Q1 2017: $18.35 million | Q2 2017: $16.08 million | Q3 2017: $13.79 million | Q1 2018: $8.21 million | Q2 2018: $5.76 million | Q3 2018: $2.94 million | Q1 2019: $818.0 thousand | Q2 2019: -$2.24 million | Q3 2019: $5.19 million | Q1 2020: -$1.28 million | Q2 2020: $7.29 million | Q3 2020: $4.11 million | Q1 2021: $18.56 million | Q2 2021: $15.67 million | Q3 2021: $13.41 million | Q1 2022: $7.37 million | Q2 2022: $6.73 million | Q3 2022: $4.10 million | Q1 2023: $1.90 million | Q2 2023: $1.64 million | Q3 2023: -$660.0 thousand | Q1 2024: -$2.28 million | Q2 2024: -$1.96 million | Q3 2024: $2.75 million | Q1 2025: -$1.52 million | Q2 2025: -$1.89 million | Q3 2025: $2.63 million.
- Over the full 17 years of available data (2009 to 2025), BioCardia, Inc.'s Stockholders Equity has declined by 93.9%.
- Historical annual values: Fiscal year 2025: $895.0 thousand | Fiscal year 2024: $837.0 thousand | Fiscal year 2023: -$1.60 million | Fiscal year 2022: $4.89 million | Fiscal year 2021: $10.38 million | Fiscal year 2020: $19.18 million | Fiscal year 2019: $2.37 million | Fiscal year 2018: $3.79 million | Fiscal year 2017: $11.13 million | Fiscal year 2016: $20.58 million | Fiscal year 2015: -$3.44 million | Fiscal year 2014: -$43.12 million | Fiscal year 2013: $13.31 million | Fiscal year 2012: $13.29 million | Fiscal year 2011: $12.98 million | Fiscal year 2010: $3.28 million | Fiscal year 2009: $14.74 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: